Bank of New York Mellon’s Abeona Therapeutics ABEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.21M Buy
212,179
+90,727
+75% +$515K ﹤0.01% 3017
2025
Q1
$578K Hold
121,452
﹤0.01% 3362
2024
Q4
$676K Hold
121,452
﹤0.01% 3347
2024
Q3
$768K Sell
121,452
-1
-0% -$6 ﹤0.01% 3274
2024
Q2
$515K Buy
121,453
+2,434
+2% +$10.3K ﹤0.01% 3565
2024
Q1
$863K Buy
119,019
+105,699
+794% +$766K ﹤0.01% 3224
2023
Q4
$66.7K Buy
13,320
+386
+3% +$1.93K ﹤0.01% 4133
2023
Q3
$54.5K Hold
12,934
﹤0.01% 4147
2023
Q2
$52.1K Buy
+12,934
New +$52.1K ﹤0.01% 4163
2022
Q3
Sell
-1,763
Closed -$9K 4546
2022
Q2
$9K Hold
1,763
﹤0.01% 4552
2022
Q1
$14K Hold
1,763
﹤0.01% 4627
2021
Q4
$15K Sell
1,763
-2,153
-55% -$18.3K ﹤0.01% 4598
2021
Q3
$110K Hold
3,916
﹤0.01% 4309
2021
Q2
$153K Sell
3,916
-7,053
-64% -$276K ﹤0.01% 4143
2021
Q1
$516K Sell
10,969
-260
-2% -$12.2K ﹤0.01% 3666
2020
Q4
$441K Buy
11,229
+798
+8% +$31.3K ﹤0.01% 3676
2020
Q3
$266K Sell
10,431
-326
-3% -$8.31K ﹤0.01% 3760
2020
Q2
$784K Buy
10,757
+798
+8% +$58.2K ﹤0.01% 3241
2020
Q1
$524K Buy
9,959
+1,968
+25% +$104K ﹤0.01% 3337
2019
Q4
$652K Buy
7,991
+2,114
+36% +$172K ﹤0.01% 3451
2019
Q3
$333K Sell
5,877
-472
-7% -$26.7K ﹤0.01% 3737
2019
Q2
$759K Buy
6,349
+760
+14% +$90.9K ﹤0.01% 3375
2019
Q1
$1.03M Sell
5,589
-1
-0% -$184 ﹤0.01% 3156
2018
Q4
$998K Sell
5,590
-122
-2% -$21.8K ﹤0.01% 3101
2018
Q3
$1.83M Buy
5,712
+51
+0.9% +$16.3K ﹤0.01% 2888
2018
Q2
$2.27M Sell
5,661
-35
-0.6% -$14K ﹤0.01% 2786
2018
Q1
$2.04M Sell
5,696
-2,123
-27% -$761K ﹤0.01% 2787
2017
Q4
$3.1M Buy
7,819
+3,699
+90% +$1.47M ﹤0.01% 2587
2017
Q3
$1.76M Buy
4,120
+120
+3% +$51.1K ﹤0.01% 2912
2017
Q2
$640K Buy
4,000
+2,323
+139% +$372K ﹤0.01% 3485
2017
Q1
$210K Buy
1,677
+934
+126% +$117K ﹤0.01% 3862
2016
Q4
$90K Buy
+743
New +$90K ﹤0.01% 4039
2016
Q2
Sell
-823
Closed -$53K 4313
2016
Q1
$53K Buy
823
+77
+10% +$4.96K ﹤0.01% 4069
2015
Q4
$63K Buy
746
+11
+1% +$929 ﹤0.01% 4114
2015
Q3
$74K Sell
735
-312
-30% -$31.4K ﹤0.01% 4133
2015
Q2
$132K Buy
+1,047
New +$132K ﹤0.01% 3983